FOR IMMEDIATE RELEASE
April 11, 2026
Contact: Media Relations Department | BioNova Health Sciences Tampa, Florida media@bionovahealth.com (813) 555-0192
BREAKING: TAMPA BIOTECH FIRM LANDS $50 MILLION PARTNERSHIP DEAL, PLEDGES 300 NEW FLORIDA JOBS
TAMPA, FL — BioNova Health Sciences, a rapidly growing Tampa-based biotechnology company specializing in advanced diagnostic testing and personalized medicine, today announced a landmark $50 million strategic partnership with global pharmaceutical leader MedAxis International. The agreement, signed this week at BioNova’s Tampa headquarters, is expected to generate more than 300 new high-wage jobs across the Tampa Bay region over the next three years.
The partnership will fund the expansion of BioNova’s state-of-the-art research and manufacturing campus in the Westshore Business District, adding over 120,000 square feet of laboratory and production space. The new facility is slated to break ground in Q3 2026 and is projected to be fully operational by early 2028.
“This is a transformative moment not just for BioNova, but for Tampa Bay and the entire state of Florida,” said Dr. Sandra Reyes, Founder and CEO of BioNova Health Sciences. “We are proud to be investing in our local workforce and bringing cutting-edge medical innovation right here to the heart of Florida.”
The new positions will span a range of disciplines including biochemistry research, clinical data analysis, regulatory compliance, quality assurance, and advanced manufacturing. Average salaries for the new roles are expected to exceed $75,000 annually, well above the regional median, providing a significant economic boost to Hillsborough County.
Florida Governor’s office released a statement praising the announcement, calling it “a testament to Florida’s thriving business climate and our commitment to attracting world-class innovation.”
BioNova Health Sciences was founded in 2018 and has grown to over 400 employees across its Tampa and Orlando locations. The company’s flagship product, the NovaDx early detection platform, has been adopted by hospitals in 12 states and is currently under review for FDA expanded approval.MedAxis International, headquartered in Zurich, Switzerland, operates in more than 60 countries and has invested significantly in expanding its U.S. biotech portfolio in recent years.
The deal is expected to close fully by May 2026, pending standard regulatory review.
About BioNova Health Sciences:
BioNova Health Sciences is a Tampa, Florida-based biotechnology company dedicated to advancing early disease detection and personalized treatment solutions. For more information, visit www.bionovahealth.com.
About MedAxis International:
MedAxis International is a global pharmaceutical and diagnostics leader with operations in over 60 countries. For more information, visit www.medaxisinternational.com.
Building on the momentum of BioNova Health Sciences’ expansion in Tampa, it’s clear that Florida’s economic landscape is shifting rapidly across multiple sectors. From high-tech biotech breakthroughs to massive infrastructure investments and workforce development, the Sunshine State is cementing its reputation as a premier hub for corporate growth and innovation.
To get a broader view of the strategic developments shaping Florida’s future, explore these related insights:
- Workforce & Infrastructure: As companies like BioNova bring hundreds of high-wage jobs to the region, the pressure on local infrastructure grows. South Florida Developers Race to Close Workforce Housing Gap examines how the state is addressing the housing needs of this expanding workforce.
- Logistics & Scale: The biotech sector isn’t the only one scaling; Amazon’s Operations in Florida provides a look at how major global players are leveraging Florida’s logistics network to drive regional economic impact.
- Skills Training: Sustaining this growth requires a steady pipeline of talent. The focus on Construction Apprenticeship Training South Fl highlights the critical role of vocational education in supporting Florida’s physical expansion.
- Policy Support: Legislative backing remains a cornerstone of this progress. Recent actions, such as when Governor Ron DeSantis Signs Legislation to Support Florida Veterans, demonstrate the state’s ongoing commitment to integrating skilled populations into the thriving private sector.
